BTIG’s $110 price target implies that shares of Sphere Entertainment could rally 18% from here.
Jefferies says to buy the dip in Meta, reiterates stock as top pick
Jefferies’ $910 price target offers upside of 48% for shares of Meta.
Thursday’s big stock stories: What’s likely to move the market in the next trading session
The Dow Industrials jumped nearly 590 points Wednesday after President Trump called off new tariffs on Europe.
These stocks are forming the dreaded ‘death cross,’ including one major AI tech play
Microsoft is one stock that could soon form the ominous ‘death cross,’ signaling to investors potential weakness.
Income investors can find dividends and outperformance in the same corner of the market
Whether it’s capital gains, dividend income or diversification, it pays for U.S. investors to look abroad.
There’s another reason why bitcoin is trailing gold and not acting as a safe haven
Quantum computing poses a risk to the security of crypto wallets and the Bitcoin network, which could be putting pressure on the oldest cryptocurrency’s price.
This oil driller’s stock shows a favorable trend in a strong sector and has momentum at its back
Momentum indicators in both the RSI and MACD flashed buy signals and are not in overbought territory. There’s room to run.
Broadcom CEO told TD Cowen analysts there’s insatiable demand for its chips
The investment bank reiterated its bullish $450 price target on Broadcom shares after hosting a meeting with the company’s CEO.
CVS is getting repriced and presents a compelling bullish setup into 2026
With CVS re-establishing forward guidance and offering a deeply discounted valuation, the balance of risk favors upside.
This biotech stock has plummeted over the past year. RBC sees big turnaround ahead
RBC’s $22 price target implies an upside of 74% for shares of Biohaven.